Skip to content

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06121661
Enrollment
20
Registered
2023-11-08
Start date
2023-02-21
Completion date
2028-12-14
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds and Injuries

Brief summary

This is a pilot evaluation of the APPRAISE trauma decision-support software system (the System). The specific objections are as follows: 1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use); 2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits; 3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.

Interventions

DEVICEAPPRAISE Trauma Clinical Decision Support System

Real-time bedside decision-support system for trauma patient management

Sponsors

Andrew Tomas Reisner
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (≥18 yrs) Emergency Department (ED) patient * Triaged to the Acute area of the ED. (The Acute area is the designated area for ED patients with potential or established critical illness. Triage to Acute is a routine ED operation that is performed based on departmental guidelines and the professional judgement of an experienced triage nurse). * Clinical concern for acute injury (based on either an explicitly chief complaint of acute injury, or clinical team with documented concern for acute injury as a relevant part of patient presentation).

Exclusion criteria

* Prisoners * Patients known to be pregnant, based on patient report, physical exam, or bedside ultrasound * Patients wearing an EFIC Opt-Out bracelet * Any concern about the suitability of the software system for a specific patient by any clinician involved in the patient's ED care, or by the patient themselves (or by any LAR \[lawfully authorized representative\] of the patient).

Design outcomes

Primary

MeasureTime frameDescription
Software session with error messages or critical software errorsFrom patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation).Each time the software is used (session), a log file is generated. We will quantify how many sessions generate error messages or critical software errors.
Clinician surveys that the software negatively affected patient careFrom patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)Each time the software is used, clinicians are surveyed whether the software negatively affected patient care, in their professional judgement
Clinician surveys that the software positively affected patient careFrom patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)Each time the software is used, clinicians are surveyed whether the software negatively affected patient care, in their professional judgement
Clinician surveys that ongoing use of the software poses risks that exceeds benefitsFrom patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)Each time the software is used, clinicians are surveyed whether ongoing use of the software poses risks that exceeds benefits

Countries

United States

Contacts

Primary ContactIain Kehoe
ikehoe@mgh.harvard.edu6177262241

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026